Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41

被引：0

作者：

Aning, Jonathan ^{[1
]}

McCoubrie, Paul ^{[1
]}

Oxley, Jon ^{[1
]}

机构：

[1] North Bristol NHS Trust, Bristol Urol Inst, Bristol BS10 5NB, Avon, England

来源：

EUROPEAN UROLOGY | 2020年 / 78卷 / 05期

关键词：

D O I：

10.1016/j.eururo.2020.07.035

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E198 / E199

页数：2

共 12 条

[1] Reply to Jonathan Aning, Paul McCoubrie, and Jon Oxley's Letter to the Editor re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imagingtargeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41
Gandaglia, Giorgio
Montorsi, Francesco
Briganti, Alberto
EUROPEAN UROLOGY, 2020, 78 (05) : E200 - E200
[2] Re: The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy
Radtke, Jan Philipp
Nyarangi-Dix, Joanne
Wiesenfarth, Manuel
Hadaschik, Boris
EUROPEAN UROLOGY, 2021, 79 (01) : 164 - 165
[3] Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy. Eur Urol Oncol 2020;7:739-47
Morka, Naomi
Simpson, Benjamin S.
Emberton, Mark
Norris, Joseph M.
EUROPEAN UROLOGY ONCOLOGY, 2021, 4 (01): : 127 - 128
[4] The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging ?targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy
Gandaglia, Giorgio
Ploussard, Guillaume
Valerio, Massimo
Mattei, Agostino
Fiori, Cristian
Roumiguie, Mathieu
Fossati, Nicola
Stabile, Armando
Beauval, Jean-Baptiste
Malavaud, Bernard
Scuderi, Simone
Barletta, Francesco
Moschini, Marco
Zamboni, Stefania
Rakauskas, Arnas
Tian, Zhe
Karakiewicz, Pierre I.
De Cobelli, Francesco
Porpiglia, Francesco
Montorsi, Francesco
Briganti, Alberto
EUROPEAN UROLOGY, 2020, 77 (06) : 733 - 741
[5] Re: Frank-Jan H. Drost, Daniel Osses, Daan Nieboer, et al. Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis. Eur Urol 2020;77:78-94 Are Targeted Prostate Biopsies Enough in Men with a Previous Negative Biopsy?
Morote, Juan
Celma, Anna
Planas, Jacques
EUROPEAN UROLOGY, 2020, 77 (05) : E138 - E139
[6] Re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2019;76:284-303 Threshold Indication for Magnetic Resonance Imaging-targeted Biopsy in the Detection of Prostate Cancer
Kim, Jae Heon
Jeong, In Gab
EUROPEAN UROLOGY, 2020, 77 (05) : E134 - E135
[7] Re: Guillaume Ploussard, Eric Barret, Gaëlle Fiard, et al. Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFUPR1). Eur Urol Oncol. In press. https://doi.org/10.1016/ j.euo.2024.01.019
Lin, Fu-Xiang
Yu, Yi
Xu, Zhan-Ping
EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (06): : 1549 - 1550
[8] Re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review And Meta-analysis. Eur Urol 2019;76:284-303
Montorsi, Francesco
Gandaglia, Giorgio
Briganti, Alberto
EUROPEAN UROLOGY, 2019, 76 (05) : E132 - E132
[9] Reply to Francesco Montorsi, Giorgio Gandaglia, Alberto Briganti's Letter to the Editor, re: Veeru Kasivisvanathan, Armando Stabile, Joana B. Neves, et al. Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review, Meta-analysis. Eur Urol 2019;76:284-303 The choice of diagnostic test in prostate cancer is a balance of the risks and benefits: One size may not fit all
Kasivisvanathan, Veeru
Takwoingi, Yemisi
Emberton, Mark
Moore, Caroline M.
EUROPEAN UROLOGY, 2019, 76 (05) : E133 - E134
[10] Reply to Francesco Montorsi, Giorgio Gandaglia, Nicola Fossati, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51
Stavrinides, Vasilis
Giganti, Francesco
Emberton, Mark
Moore, Caroline M.
EUROPEAN UROLOGY, 2020, 78 (04) : E166 - E166

← 1 2 →